Trial Information

Summary: New prevention medication trial for migraine sufferers

A study to test two different doses of a new oral migraine prevention medicine (Lacosamide)against placebo to decrease frequency of migraines.

Patient Inclusion Criteria

  • 18-65 years of age
  • 2-8 migraine episodes per month
  • No more than 15 headache days per month in last two months
  • Not using headache treatment medication more than twice per week in last two months must be able to discontinue current prevention medications, but not abortive/acute medications

Patient Exclusion Criteria

  • more than 15 headache days per month in either of prior two months.
  • use of migraine treatment medication more than twice per week in either of last two months.

Contact:

Pam Lemme, R.N., B.S.N.
Alpine Clinical Research Center
1000 Alpine Ave., Ste. 200
Boulder, CO 80304
Telephone: 303-443-7229
Email:

Profile Page: Alpine Clinical Research Center, Boulder, CO

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 6:31:39 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA